Sign inJoin waitlistJoin the waitlist

Arun Sanyal

Division Chief · Virginia Commonwealth University Health System

Credentials: · · · ·

History

Virginia Commonwealth University Health System
Present

Gastroenterology
Virginia Commonwealth University Health System
1987–1990
Internal Medicine
1981–1984
Maulana Azad Medical College
1977–1981

Research

Design and validation of a histological scoring system for nonalcoholic fatty liver disease
Hepatology · 2005 · 9,104 citations
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Hepatology · 2018 · Last of 9 authors · 5,460 citations
Mechanisms of NAFLD development and therapeutic strategies
Review · Nature Medicine · 2018 · Last of 4 authors · 3,515 citations

VL
Velimir Luketic
116 papers
Rohit Loomba
113 papers
Richard Sterling
104 papers
Shadab Siddiqui
89 papers · 32 as a fellow
Naga Chalasani
85 papers
RS
Richard Stravitz
78 papers · 1 as a fellow
Mitchell Shiffman
74 papers
SH
Stephen Harrison
70 papers
PP
Puneet Puri
66 papers · 8 as a fellow
Brent Tetri
60 papers
Mazen Noureddin
60 papers · 1 as a fellow
JB
Jasmohan Bajaj
53 papers · 4 as a fellow

Grants

ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular Carcinoma (ELEVATE)
National Cancer Institute · P01
Project lead · $1.7M · Virginia Commonwealth University
2024–2029
Integrated Therapies for Alcohol Use in Alcohol-Associated Liver Disease (ITAALD) - Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism · U01
Contact PI · $2.9M · Virginia Commonwealth University
2018–2029
CTSA K12 Program at Virginia Commonwealth University
National Center for Advancing Translational Sciences · K12
PI · $749.5K · Virginia Commonwealth University
2023–2028
Liver Cirrhosis Network: Clinical Research Centers
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2M · Virginia Commonwealth University
2021–2027

Clinical trials

Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
Principal investigator · Completed
PharmaNest, Inc
2025–2026
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
Principal investigator · Withdrawn · Phase 2
Galmed Pharmaceuticals Ltd
2025–2027
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Principal investigator · Recruiting
Foundation for the National Institutes of Health
2025–2026
Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease
Principal investigator · Withdrawn
Virginia Commonwealth University
2023